ArticleCureus2025
Clinicopathological Analysis and Its Correlation With Various Classes of Lupus Nephritis.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Heterogeneity in the efficacy of bosentan for hypertensive nephropathy: a study on individualized benefit prediction models based on pathological subtyping and dynamic trajectories.Annals of medicine · 2026Article
- Clinicopathological correlation in lupus nephritis: a 5-year tertiary center experience using International Society of Nephrology/Renal Pathology Society classification.Annals of medicine and surgery (2012) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and objectives Systemic lupus erythematosus (SLE) is a complex autoimmune disorder characterized by chronic immune complex deposition and involvement of multiple organ systems. Among individuals with SLE, a greater percentage are at a higher risk of developing lupus nephritis (LN). Renal biopsies play a pivotal role in diagnosing, managing, and predicting the prognosis of LN. The classification of LN relies heavily on light microscopy findings, supplemented by histochemistry, direct immunofluorescence, and electron microscopy. Lupus nephritis is categorized into six distinct classes based on the quantitative evaluation of histological lesions. The study aimed to analyze and correlate demographic data, biochemical parameters, serological values, and histopathological features in patients with LN who underwent renal biopsies to categorize the different classes of LN based on the WHO and International Society of Nephrology (ISN)/Renal Pathology Society (RPS) 2003 classification systems. The study also aimed to establish correlations with the National Institutes of Health (NIH) activity and chronicity indices of LN. Methods and results This retrospective study included 102 patients diagnosed with SLE who underwent renal biopsies confirming LN. Among the 102 cases of LN, patients were grouped into two categories: those with active LN (61 cases) and those without active LN (41 cases). The most commonly observed histological subtype was class IV/V LN, followed by isolated class IV LN, both of which were associated with higher activity scores based on the NIH scoring system for LN. The findings emphasize that the majority of patients with SLE present with features of active disease (class IV or combined class IV/V) at the time of diagnosis and often progress to chronicity within a short timeframe. Additionally, the presence of antibodies related to other autoimmune diseases also had an impact on patients' progression to end-stage renal disease (ESRD) and overall prognosis. Conclusion The study highlights the critical role of histological classification in diagnosing and predicting the prognosis of LN. Active LN, particularly class IV or class IV/V combined, is more common at diagnosis and often progresses to chronicity. Regular monitoring using the modified NIH activity and chronicity scores, along with routine renal profiling and urine analysis, is essential to support the need for repeat renal biopsies during treatment. This approach enables the early detection of higher-class transitions. The prognostic value of histological scoring has been well established, underscoring the importance of both activity and chronicity indices in guiding therapeutic strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.